:: Library Catalog

Image de couverture de livre

Enregistré dans:

Détails bibliographiques
Auteur principal:	Mamoor, Shahan
Format:	Recurso digital
Langue:
Publié:	Zenodo 2025
Accès en ligne:	https://doi.org/10.5281/zenodo.16951485
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

A comprehensive description of the circulating tumor cell: ITGAD.
par: Mamoor, Shahan
Publié: (2025)

A comprehensive description of the circulating tumor cell: TMEM25.
par: Mamoor, Shahan
Publié: (2025)

A comprehensive description of the circulating tumor cell: EXD3.
par: Mamoor, Shahan
Publié: (2025)

A comprehensive description of the circulating tumor cell: HCAR1.
par: Mamoor, Shahan
Publié: (2025)

A comprehensive description of the circulating tumor cell: GPRC5A.
par: Mamoor, Shahan
Publié: (2025)

A comprehensive description of the circulating tumor cell: TM6SF1.
par: Mamoor, Shahan
Publié: (2025)

A comprehensive description of the circulating tumor cell: Fzd4/Fzd3.
par: Mamoor, Shahan
Publié: (2025)

The integral membrane protein SMIM38 is transcriptionally activated in circulating tumor cells in human breast cancer in conjunction with two SMIM38-interacting proteins of undefined function, ETDA and ETDB.
par: Mamoor, Shahan
Publié: (2025)

Therapeutic targeting in colorectal cancer for the treatment of the primary tumor: MAT1A.
par: Mamoor, Shahan
Publié: (2025)

Therapeutic targeting in colorectal cancer for the treatment of the primary tumor: TGFBI.
par: Mamoor, Shahan
Publié: (2025)

Therapeutic targeting in colorectal cancer for the treatment of the primary tumor: BUB1.
par: Mamoor, Shahan
Publié: (2025)

Therapeutic targeting in colorectal cancer for the treatment of the primary tumor: GALNT6.
par: Mamoor, Shahan
Publié: (2025)

Therapeutic targeting in colorectal cancer for the treatment of the primary tumor: KIF11.
par: Mamoor, Shahan
Publié: (2025)

Therapeutic targeting in colorectal cancer for the treatment of the primary tumor: SKP2.
par: Mamoor, Shahan
Publié: (2025)

MRPS31P5: Therapeutic targeting in colorectal cancer for the treatment of the primary tumor.
par: Mamoor, Shahan
Publié: (2025)

A relationship between p53 and Braf in mammalian cells.
par: Mamoor, Shahan
Publié: (2026)

PAXX is activated in aging blood cells.
par: Mamoor, Shahan
Publié: (2025)

Feedback activation of VEGF-A resulting from PAX8 inhibition in cancer cells.
par: Mamoor, Shahan
Publié: (2026)

An intrinsic link between the EMT program and aging in human cells.
par: Mamoor, Shahan
Publié: (2025)

NLRP11 detects activation of CIDE cell death effectors.
par: Mamoor, Shahan
Publié: (2025)

A retrotransposon-like gene, RTL5, is modulated during differentiation of embryonic stem cells to the trophectoderm lineage.
par: Mamoor, Shahan
Publié: (2026)

Clec2b and Clec11a, co-receptors for KIR2DL3 natural killer cell self discrimination complexes, are altered in expression in the cells of patients with IBD.
par: Mamoor, Shahan
Publié: (2025)

The range of Xist transcriptional targets in non-small cell lung cancer: MYC.
par: Mamoor, Shahan
Publié: (2025)

The range of Xist transcriptional targets in non-small cell lung cancer: BTBD7.
par: Mamoor, Shahan
Publié: (2025)

Fam234b is selectively activated during the first cell division of the human embryo.
par: Mamoor, Shahan
Publié: (2026)

ABC transporter multi-drug resistance genes ("pumps") in humans with non-small cell lung cancer.
par: Mamoor, Shahan
Publié: (2025)

Pulmonary dendritic cells (CD11b(hi) CD14(hi) DC) are enriched for nestin.
par: Mamoor, Shahan
Publié: (2025)

Casz1 mobilization during TE lineage specification from the pluripotent state in embryonic stem cells.
par: Mamoor, Shahan
Publié: (2026)

Kinase targeting in Luminal A breast cancer: PIK3R1.
par: Mamoor, Shahan
Publié: (2025)

Therapeutic targeting in breast cancer for the treatment of lung metastasis: PPP1R9A.
par: Mamoor, Shahan
Publié: (2025)

Therapeutic targeting in breast cancer for the treatment of lung metastasis: PPP1R9A.
par: Mamoor, Shahan
Publié: (2025)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: ERO1A.
par: Mamoor, Shahan
Publié: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: SLC1A1.
par: Mamoor, Shahan
Publié: (2025)

MAP3K6 functions in compensatory feedback signaling during clinical interventions featuring use of the VEGF-A inhibitor bevacizumab.
par: Mamoor, Shahan
Publié: (2025)

NLRP7 engagement in transformation and etiology of chronic disease.
par: Mamoor, Shahan
Publié: (2025)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: AIM1.
par: Mamoor, Shahan
Publié: (2025)

Therapeutic targeting in breast cancer for the treatment of liver metastasis: AFM.
par: Mamoor, Shahan
Publié: (2025)

Therapeutic targeting in breast cancer for the treatment of lymph node metastasis: MTF1.
par: Mamoor, Shahan
Publié: (2025)

Xist is activated during resistance in triple negative breast cancer in vitro.
par: Mamoor, Shahan
Publié: (2025)

Importin 8 is activated in childhood brain cancer.
par: Mamoor, Shahan
Publié: (2025)